Prеglеdаnjе prеmа Аutоr Đanić, Maja


Ili, izаbеritе pismо ispоd kаkо bistе prеglеdаli prеzimе
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Prikаzivаnjе rеzultаtа 15 do 22 od 22 < prеthоdnа 
Dаtum izdаvаnjаNаslоvАutоr(i)
2019New pharmaceutical formulations and new indications for an old drug - methotrexateSvetlana Goločorbin-Kon ; Nebojša Pavlović ; Saša Vukmirović ; Maja Đanić ; Boris Milijašević ; Milica Paut Kusturica ; Ana Tomas Petrović ; Bojan Stanimirov ; Hani Al-Salami; Momir Mikov 
2018Non-toxic bile acids as pharmaceutical excipients may alter pharmacological activity of antitumor drug vorinostatNebojša Pavlović ; Karmen Stankov ; Svetlana Goločorbin-Kon ; Mladena Lalić-Popović ; Bojan Stanimirov ; Maja Đanić ; Momir Mikov 
1-јан-2018Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndromeMaja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Hani Al-Salami; Karmen Stankov ; Momir Mikov 
1-јун-2018Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and ProbioticsMomir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami
1-дец-2017The Role of Drug Metabolites in the Inhibition of Cytochrome P450 EnzymesMomir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami
2019Semisynthetic bile acids: a new therapeutic option for metabolic syndromeLazarević, Slavica; Đanić, Maja ; Goločorbin-Kon, Svetlana ; Al-Salami, Hani; Mikov, Momir 
2019Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria ModelMaja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Saša Vukmirović ; Jelena Lazić; Hani Al-Salami; Momir Mikov 
2017Ursodeoxycholic acid sensitizes human breast adenocarcinoma cells to doxorubicin-induced apoptosisBojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Velibor Vasović ; Momir Mikov